Thickened heart muscle:
does it always mean hypertrophic cardiomyopathy?

Article written and reviewed by Dr Luca Moretti

No. A "thickened heart" or a "thickened left ventricle" does not automatically mean hypertrophic cardiomyopathy. Increased wall thickness can result from high blood pressure, adaptation to intense training, some valve diseases or infiltrative and storage conditions such as amyloidosis and Fabry disease.
Hypertrophic cardiomyopathy is one of the possible causes, but reading a number on an echocardiogram is not enough to diagnose it. It is necessary to establish whether the thickness is truly abnormal for that person and whether it can be explained by other conditions that place a greater load on the heart.

The main possibilities that need to be distinguished are:

• hypertrophic cardiomyopathy;
• hypertrophy caused by chronic high blood pressure;
• physiological remodeling of the athlete's heart;
• valve diseases that increase the load on the left ventricle;
• cardiac amyloidosis;
• Fabry disease and other storage diseases;
• rarer syndromic or metabolic forms.

Hypertrophic cardiomyopathy is defined in adults by the presence of increased left ventricular wall thickness that is not explained solely by loading conditions. The distinction is important because prognosis, screening of family members and treatment change radically according to the cause of the thickening.

What "thickened walls" means on an echocardiogram

An echocardiogram measures the thickness of the walls of the left ventricle, particularly the interventricular septum and posterior wall, and describes how the thickening is distributed. The finding is often called left ventricular hypertrophy, but this term describes a phenotype rather than an etiological diagnosis.
Not only the number of millimeters matters, but also the distribution of hypertrophy, cavity dimensions, diastolic and systolic function, atria, valves and any obstruction of the outflow tract.

In adults, a maximum wall thickness of at least 15 mm that is not explained by loading conditions is a fundamental criterion for the diagnosis of hypertrophic cardiomyopathy. Values of 13-14 mm, on the other hand, represent a range that requires interpretation: they may be diagnostic in the presence of a clear family history, a pathogenic genetic variant or other characteristic findings.
For this reason, a report stating "septum 14 mm" is not sufficient on its own to conclude either that hypertrophic cardiomyopathy is present or that it is excluded.

Hypertension: one of the most common causes of ventricular hypertrophy

When blood pressure remains high for a long time, the left ventricle has to generate greater pressure to eject blood. As an adaptation, muscle mass may increase and left ventricular hypertrophy may develop. Hypertension guidelines consider this finding a form of hypertension-mediated organ damage.
The pattern often tends to be relatively concentric, meaning a diffuse increase in thickness, but morphology is not always sufficient to distinguish hypertension from hypertrophic cardiomyopathy with certainty.

Diagnosis therefore requires reliable blood pressure measurements, possibly also at home or with 24-hour monitoring, in addition to cardiac assessment. Apparently normal pressures during a single visit do not exclude masked hypertension or a long history of elevated values in the past.
Blood pressure control can promote regression of hypertrophy and reduce cardiovascular risk, whereas in sarcomeric hypertrophic cardiomyopathy the mechanism is different and the clinical pathway follows specific rules.

Athlete's heart or hypertrophic cardiomyopathy?

Intense and prolonged training can produce a physiological adaptation known as athlete's heart. The ventricle may increase in size and, in some athletes, the walls may become thicker. This phenomenon can overlap with values seen in mild forms of hypertrophic cardiomyopathy, creating a so-called diagnostic gray zone.
In physiological athletic remodeling, increased wall thickness is often accompanied by a larger ventricular cavity and good diastolic function; in hypertrophic cardiomyopathy, the thickening is frequently regional or asymmetric and may be associated with other electrical and structural abnormalities.

No single criterion resolves every case. ECG, advanced echocardiography, cardiac magnetic resonance imaging, response to exercise, family history and genetics can be integrated when uncertainty persists. Cardiac MRI is particularly useful for accurately measuring the distribution of hypertrophy and looking for fibrosis or other tissue patterns that are incompatible with simple physiological adaptation.

Amyloidosis, Fabry disease and other diseases that can mimic hypertrophic cardiomyopathy

Not everything that appears to be "thicker muscle" represents true hypertrophy of muscle cells. In cardiac amyloidosis, for example, extracellular deposition of amyloid fibrils increases the apparent thickness of the walls and can produce a phenotype similar to hypertrophic cardiomyopathy. Suspicion increases in the presence of specific cardiac and extracardiac signs, especially at older ages.

Cardiomyopathy in Fabry disease can also present with ventricular hypertrophy, sometimes with predominant cardiac involvement. Storage diseases such as Danon disease, Pompe disease and PRKAG2 syndrome are rarer, but they are part of the differential diagnosis when age, ECG, family history or extracardiac manifestations suggest them.
Recognizing these conditions is essential because some have specific treatments and because the risk to family members may differ from that of sarcomeric hypertrophic cardiomyopathy.

Which tests clarify the cause of a thickened heart muscle?

The first step is to reconstruct the context: age, blood pressure, training level, symptoms, medications, family history of cardiomyopathy or sudden death, and the presence of extracardiac signs. ECG and echocardiography show the initial phenotype, but in unclear cases cardiac magnetic resonance imaging can be decisive in measuring the walls more accurately and characterizing the tissue.
The distribution of fibrosis, T1 values and extracellular volume can point toward sarcomeric disease, Fabry disease, amyloidosis or other processes, although they do not replace the specific investigations needed to confirm the diagnosis.

Depending on the suspected cause, genetic testing, measurement of alpha-galactosidase A activity and lyso-Gb3, studies for monoclonal proteins, bone-tracer scintigraphy or other targeted tests may be requested. There is therefore no single "test for a thickened heart": the correct pathway begins with the phenotype and progressively narrows the possible causes.
If thickening is discovered incidentally in an asymptomatic person, it is not necessarily an emergency, but it deserves appropriate assessment. Syncope during exertion, significant chest pain, sustained palpitations or a family history of sudden cardiac death instead increase the priority of further investigation.

Frequently asked questions about a thickened heart muscle

What does it mean to have a thickened heart muscle?
It means that one or more cardiac walls are thicker than expected. It is an anatomical finding, not a definitive diagnosis.

Does a thickened left ventricle mean hypertrophic cardiomyopathy?
No. Hypertension, intense training, valve disease and infiltrative or storage diseases can produce similar patterns.

How many millimeters are needed to diagnose hypertrophic cardiomyopathy?
In adults, at least 15 mm not explained by loading conditions is a fundamental criterion; 13-14 mm may be significant in the presence of other specific findings.

Can high blood pressure thicken the heart?
Yes. Chronic hypertension can cause left ventricular hypertrophy as organ damage from high blood pressure.

Which tests distinguish the different causes?
Blood pressure, ECG, echocardiography, family and sports history and cardiac MRI form the core of the assessment; genetic testing and specific investigations are added when the clinical picture requires them.